Cytogenetic findings in adult Greek myelodysplastic syndrome patients: Predominance of single trisomy 8

In Vivo

Volumn 20, Issue 1, 2006, Pages 115-118

  Panani, Anna D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chromosome 8 aberrations; Chromosome abnormalities; Cytogenetics; Myelodysplastic syndrome

Indexed keywords

ARTICLE; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME 17Q; CHROMOSOME 18P; CHROMOSOME 1Q; CHROMOSOME 5Q; CHROMOSOME 7; CHROMOSOME 7Q; CHROMOSOME 8; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME ISOLATION; CONTROLLED STUDY; GREECE; HUMAN; INCIDENCE; KARYOTYPE; MAJOR CLINICAL STUDY; MORBIDITY; MYELODYSPLASTIC SYNDROME; ONCOGENESIS AND MALIGNANT TRANSFORMATION; QUANTITATIVE ANALYSIS; TRISOMY 8; X CHROMOSOME; Y CHROMOSOME;

EID: 30844459448     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mufti GJ: Pathobiology, classification and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 17: 543-557, 2004.
2. Chen Z and Sandberg AA: Molecular cytogenetics aspects of hematological malignancies: clinical implications. Am J Med Genet (Semin Med Genet) 115: 130-141, 2002.
3. Olney HJ and Le Beau MM: The cytogenetics of myelodysplastic syndromes. Best Pract Res Clin Haematol 14: 479-495, 2001.
4. Mhawech P and Saleem A: Myelodysplastic syndrome: review of the cytogenetic and molecular data. Crit Rev Oncol Hematol 40: 229-238, 2001.
5. Sole F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luno E, Prieto F, Granada I, Hernandez JM et al: Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol 108: 346-356, 2000.
6. Fernandez TS, Ornellas MH, de Carralho LO, Tabak D and Abdelhay E: Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia. Leuk Res 24: 839-848, 2000.
7. West RR, Stafford DA, Farrow A and Jacobs A: Occupational and environmental exposures and myelodysplasia: a case-control study. Leuk Res 19: 127-139, 1995.
8. Nisse C, Haguenoer JM, Grandbastien B, Preudhomme C, Fontaine B, Brillet JM, Lejeune R and Fenaux P: Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 112: 927-935, 2001.
9. Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N, Minotto C, Agostini P, De Angeli C, De Senno L, Spanedda R and Castoldi G: Exposure to myelotoxic agents and myelodysplasia: case control study and correlation with clinicobiological findings. Br J Haematol 103: 189-197, 1998.
10. Lee DS, Kim SH, Seo E-J, Park CJ, Chi HS, Ko EY, Yoon BH, Kim WH and Cho HI: Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study. Cancer Genet Cytogenet 132: 97-101, 2002.
11. Pedersen B: MDS and AML with trisomy 8 as the sole chromosome aberration show different sex ratios and prognostic profiles: a study of 115 published cases. Am J Hematol 56: 224-229, 1997.
12. Paulsson Y, Fioretos T, Strombeck B, Mauritzson N, Tanke HJ and Johansson B: Trisomy 8 as the sole chromosomal aberration in myelocytic malignancies: a multicolor and locus-specific fluorescence in situ hybridization study. Cancer Genet Cytogenet 140: 66-69, 2003.
13. Van den Berghe H and Michaux L: 5q-, twenty-five years later: a synopsis. Cancer Genet Cytogenet 94: 1-7, 1997.
14. Washington LBT, Doherty D, Glassman A, Martins J, Ibrahim S and Lai R: Myeloid disorders with deletion of 5q as the sole karyotype abnormality: the clinical and pathologic spectrum. Leuk Lymphoma 43: 761-765, 2002.
15. Jaju RJ, Boultwood J, Oliver FJ, Kostrzewa M, Fidler C, Parker N, McPherson JD, Morris SW, Muller U, Wainscount JS and Kearney L: Molecular cytogenetic delineation of the critical deleted region in the 5q-syndrome. Genes Chromosomes Cancer 22: 251-256, 1998.
16. Westbrook CA, Hsu WT, Chyna B, Litvak D, Raza A and Horrigan SK: Cytogenetic and molecular diagnosis of chromosome 5 deletions in myelodysplasia. Br J Haematol 110: 847-855, 2000.
17. Crescenzi B, Starza R, Romoli S, Beacci D, Matteucci C, Barda G, Aventin A, Marynen P, Ciolli S, Nozzoli C, Martelli MF and Mecucci C: Submicroscopic deletion in 5q- associated malignancies. Haematologica 89: 281-286, 2004.
18. Fairman J, Wang RY, Liang H, Zhao L, Saltman D, Liang JC and Nagarajan L: Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus. Blood 88: 2259-2266, 1996.
19. Le Beau MM, Espinosa RIII, Davis EM, Eisenbart JD, Larson RA and Green ED: Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 88: 1930-1935, 1996.
20. Fisher K, Frohling S, Sherer SW, McAllister Brown J, Scholl C, Stilgenbauer S, Tsui LC, Lichter P and Dohner H: Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 89: 2036-2041, 1997.
21. Tosi S, Sherer SW, Giudici G, Czepulkowski B, Biondi A, Kearney L: Delineation of multiple deleted regions in 7q in myeloid disorders. Genes Chromosomes Cancer 25: 384-392, 1999.
22. Horton YM and Johnson RE: Trisomy 14 in myeloid malignancies: report of two cases and review of the literature. Cancer Genet Cytogenet 124: 172-174, 2001
23. Mitelman F, Johansson B and Mertens F: Mitelman Database of Chromosome Aberration in Cancer. http://cgap.nci.nih.gov./Chromosomes/Mitelman, 2004.
24. Lai J-L, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, Lepelley P, Wattel E and Fenaux P: Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of p53 mutations. Leukemia 9: 370-381, 1995.
25. McClure RF, Dewald GW, Hover ID and Hanson CA: Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course. Br J Haematol 106: 445-454, 1999.
26. Panani AD, Pappa V, Papageorgiou S, Stamatelli F and Raptis S: Deletion of (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review. Ann Hematol 83: 153-155, 2004.